Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07615400 · ClinicalTrials.gov registry record
A Long-Term Observational Study of Patients With Fucosidosis
A clinical trial, sponsored by JCR Pharmaceuticals Co..
- Recruiting
- Registry status
- 57
- Enrollment target
NCT07615400: Recruiting study, sponsored by JCR Pharmaceuticals Co..
NCT07615400 is a clinical trial that is actively recruiting participants, run by JCR Pharmaceuticals Co.. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07615400 is actively recruiting participants, sponsored by JCR Pharmaceuticals Co..
- RECRUITING
- Registry status
- 57 participants
- Enrollment target
Study Summary
The purpose of this observational research study is to learn more about the natural history of fucosidosis, its symptoms, and how it develops over time. This study intends to collect information from participants diagnosed with fucosidosis; however, this study does not include any medication or treatment other than the usual medical care provided to study participants. The information collected in this study will be used to help understand the disease characteristics of fucosidosis; with this information potentially being able to help design future studies and treatments for this disease. There is currently no approved treatment for patients with fucosidosis. The study consists of 2 parts: a) Part A - retrospective data collection, and b) Part B - prospective data collection.
Primary Outcome
These observations are intended to inform possible future treatment studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2026-03-25 |
| Est. Completion | 2031-01 |
What NCT07615400 shows while recruiting
NCT07615400 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07615400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07615400 about?
NCT07615400 is a clinical study titled "A Long-Term Observational Study of Patients With Fucosidosis". The purpose of this observational research study is to learn more about the natural history of fucosidosis, its symptoms, and how it develops over time. This study intends to collect information from participants diagnosed with fucosidosis; however, this study does not include any medication or tre...
What is the current status of trial NCT07615400?
This trial is currently recruiting. The enrollment target is 57 participants. The study started on 2026-03-25. Estimated completion is 2031-01.
Who is sponsoring clinical trial NCT07615400?
This trial is sponsored by JCR Pharmaceuticals Co., which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI